Cannabis Tax Changes Could Trigger 504% Cash Flow Leap, Which Industry Players Will Benefit?
The Department of Health and Human Services’ recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market.One day follo…